SK Bioscience Co.,Ltd
A biopharma firm developing and manufacturing vaccines and offering CDMO services.
302440 | KO
Overview
Corporate Details
- ISIN(s):
- KR7302440003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 310, 성남시
- Website:
- https://www.skbioscience.com/
- Sector:
- Manufacturing
Description
SK Bioscience is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines and biological products. Spun off from SK Chemicals in 2018, the company develops its own pipeline of vaccines, including cell-culture-based influenza vaccines and a COVID-19 vaccine, utilizing its established R&D and production platforms. In addition to its proprietary products, SK Bioscience provides global Contract Development and Manufacturing Organization (CDMO) services, offering end-to-end support from process development to large-scale commercial manufacturing for international partners. The company is dedicated to promoting public health by providing innovative preventative solutions to address global health challenges.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-06 00:00 |
[기재정정]투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 미국 제3상 임상시험계획 (IND) 신청)
|
Korean | 35.8 KB | ||
| 2024-07-31 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 14.9 KB | ||
| 2024-07-31 00:00 |
기업설명회(IR)개최(안내공시)
|
Korean | 6.1 KB | ||
| 2024-07-26 00:00 |
기업설명회(IR)개최(안내공시)
|
Korean | 6.1 KB | ||
| 2024-06-28 00:00 |
기타시장안내 (업종변경)
|
Korean | 5.8 KB | ||
| 2024-06-27 00:00 |
타법인주식및출자증권취득결정(종속회사의주요경영사항)
|
Korean | 23.2 KB | ||
| 2024-06-27 00:00 |
타인에대한채무보증결정
|
Korean | 17.1 KB | ||
| 2024-06-27 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 34.6 KB | ||
| 2024-06-24 00:00 |
투자판단관련주요경영사항 (21가 폐렴구균백신GBP410의 호주 제3상 임상시험계획 IND 승인)
|
Korean | 10.9 KB | ||
| 2024-06-04 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 7.7 KB | ||
| 2024-05-31 00:00 |
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
|
Korean | 118.3 KB | ||
| 2024-05-31 00:00 |
기업지배구조보고서공시
|
Korean | 2.9 MB | ||
| 2024-05-17 00:00 |
투자판단관련주요경영사항 (COVID-19 백신 스카이코비온(GBP510)의 영국 MHRA 품목허가(Marketing A…
|
Korean | 8.8 KB | ||
| 2024-05-14 00:00 |
분기보고서 (2024.03)
|
Korean | 1.6 MB | ||
| 2024-05-10 00:00 |
투자판단관련주요경영사항 (COVID-19 백신 스카이코비원 세계보건기구(WHO) 긴급사용목록(Emergency Use …
|
Korean | 8.6 KB |
Automate Your Workflow. Get a real-time feed of all SK Bioscience Co.,Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SK Bioscience Co.,Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SK Bioscience Co.,Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
